More than 30 years ago, we published a paper entitled as “Abnormal Chromatin Configuration and Oncogenesis”, which proposed the first hy-pothesis that links oncogenesis to abnormal three-dimensional (3D) genome structure. Recently, many studies have demonstrated that the 3D genome structure plays a major role in oncogenesis, which strongly supports our hypothesis. In this paper, further thoughts about our hypothesis are presented.
References
[1]
Li, G.D. (1986) Abnormal Chromatin Configuration and Oncogenesis. Medicine and Philosophy, 7, 12-14. (In Chi-nese)
[2]
Dekker, J., Rippe, K., Dekker, M. and Kleckner, N. (2002) Capturing Chromosome Conformation. Science, 295, 1306-1311. https://doi.org/10.1126/science.1067799
[3]
Risca, V.I. and Greenleaf, W.J. (2015) Unraveling the 3D Genome: Genomics Tools for Multiscale Exploration. Trends in Genetics, 31, 357-372. https://doi.org/10.1016/j.tig.2015.03.010
[4]
Corces, M.R. and Corces, V.G. (2016) The Three-Dimensional Cancer Genome. Current Opinion in Genetics & Development, 36, 1-7. https://doi.org/10.1016/j.gde.2016.01.002
[5]
Dowen, J.M., Fan, Z.P., Hnisz, D., Ren, G., Abraham, B.J., Zhang, L.N., Weintraub, A.S., Schujiers, J., Lee, T.I., Zhao, K. and Young, R.A. (2014) Control of Cell Identity Genes Occurs in Insulated Neighborhoods in Mammalian Chromosomes. Cell, 159, 374-387. https://doi.org/10.1016/j.cell.2014.09.030
[6]
Mazumdar, C., Shen, Y., Xavy, S., Zhao, F., Reinisch, A., Li, R., Corces, M.R., Flynn, R.A., Buenrostro, J.D., Chan, S.M., Thomas, D., Koenig, J.L., Hong, W.J., Chang, H.Y. and Majeti, R. (2015) Leukemia-Associated Cohesin Mutants Dominantly Enforce Stem Cell Programs and Impair Human Hematopoietic Progenitor Differentiation. Cell Stem Cell, 17, 675-688. https://doi.org/10.1016/j.stem.2015.09.017
[7]
Dixon, J.R., Jung, I., Selvaraj, S., Shen, Y., Antosiewicz-Bourget, J.E., Lee, A.Y., Ye, Z., Kim, A., Rajagopal, N., Xie, W., et al. (2015) Chromatin Architecture Reorganization during Stem Cell Differentiation. Nature, 518, 331-336. https://doi.org/10.1038/nature14222
[8]
Flavahan, W.A., Drier, Y., Liau, B.B., Gillespie, S.M., Venteicher, A.S., Stemmer-Rachamimov, A.O., Suva, M.L. and Bernstein, B.E. (2016) Insulator Dysfunction and Oncogene Activation in IDH Mutant Gliomas. Nature, 529, 110-114. https://doi.org/10.1038/nature16490
[9]
Hnisz, D., Weintraub, A.S., Day, D.S., Valton, A.L., Bak, R.O., Li, C.H., Goldmann, J., Lajoie, B.R., Fan, Z.P., Sigova, A.A., Reddy, J., Borges-Rivera, D., Lee, T.I., Jaenisch, R., Porteus, M.H., Dekker, J. and Young, R.A. (2016) Activation of Proto-Oncogenes by Disruption of Chromosome Neighborhoods. Science, 351, 1454-1458. https://doi.org/10.1126/science.aad9024
[10]
Hanahan, D. and Weinberg, R.A. (2000) The Hallmarks of Cancer. Cell, 100, 57-70. https://doi.org/10.1016/S0092-8674(00)81683-9
[11]
Dagogo-Jack, I. and Shaw, A.T. (2018) Tumour Heterogeneity and Resistance to Cancer Therapies. Nature Reviews Clinical Oncology, 15, 81-94. https://doi.org/10.1038/nrclinonc.2017.166
